2022-03-04
Published Date
Healthcare
Industry
113
Pages
Osteoarthritis Drugs global industry size is estimated to be worth US$XX million in 2022 and is forecast to a readjusted size of US$XX million by 2028 with a CAGR of XX% during the forecast period 2022-2028. Fully considering the economic change by this health crisis (Covid), Oral accounting for XX% of the Osteoarthritis Drugs global market in 2021, is projected to value US$XX million by 2028, growing at a revised XX% CAGR from 2023 to 2028. While Hospital Pharmacies segment is altered to an XX% CAGR throughout this forecast period.
The global key companies of Osteoarthritis Drugs include Johnson & Johnson, Pfizer, Eli Lilly, Abbott, GlaxoSmithKline, Sanofi, Flexion Therapeutics, etc. In 2022, the global top five players have a share approximately XX% in terms of revenue.
In terms of Production Side,
This report researches the Osteoarthritis Drugs capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of Sales Side,
This report focuses on the sales of Osteoarthritis Drugs by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
This research report explores the key market segments: Type and Application. The report offers an in-depth breakdown of type and application segments, and their sub-segments. The growth potential of each segment have been examined by industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments, based on sales, price, and revenue for the period 2017-2028. Additionally, the report features a value chain and raw material analysis of the key segments.
Segment by Type
Oral
Injection
External
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The report includes a section on key growth opportunities, which will help the key players to simplify complex issues and frame future strategies to compete in this competitive environment. This section will assist the players to boldly position their business.
Competitive Outlook
This section of the report provides an in-depth analysis of the competitive landscape of the market. The report profiles the key players in the market. It also provides reliable sales and revenue data of the players for the period 2017-2022. With the help of this report, key players, stakeholders, and other participants will be able to stay up-to-date with the recent and upcoming developments in the market, further aiding them in making efficient choices. The prime players profiled in this report are:
Companies
Johnson & Johnson
Pfizer
Eli Lilly
Abbott
GlaxoSmithKline
Sanofi
Flexion Therapeutics
Note: We can also add companies which are not part of the above list
Global Osteoarthritis Drugs market: regional analysis, the major regions covered in the report are:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Q: Who are the key players in the Osteoarthritis Drugs market
A: The key players in the market are Johnson & Johnson, Pfizer, Eli Lilly, Abbott, GlaxoSmithKline, Sanofi, Flexion Therapeutics.
Q: What is the revenue and sales data of the key players of Osteoarthritis Drugs industry
A: The revenue and sales data of the key players of Osteoarthritis Drugs industry is mentioned in full report.
Q: What are the recent and upcoming developments in the Osteoarthritis Drugs market
A: The recent and upcoming developments in the Osteoarthritis Drugs market are mentioned in this report.
Q: What are the main objectives of the Osteoarthritis Drugs industry report
A: The main objectives of Osteoarthritis Drugs industry report are to provide reliable sales and revenue data of the key players and to provide a comprehensive analysis of the competitive landscape.
Q: What are the key highlights of the Osteoarthritis Drugs market research report
A: The key highlights of Osteoarthritis Drugs industry report are to help players in decision making, the revenue and sales data of other players, and the recent and upcoming developments in the market.
Q: What is the scope of the Osteoarthritis Drugs report
A: The Osteoarthritis Drugs market report covers the market for the period 2017-2028.
Q: What is the methodology of the Osteoarthritis Drugs report
A: The methodology of Osteoarthritis Drugs industry report is based on primary and secondary sources.
Table of Contents
Part 1 Market Overview
1.1 Market Definition
1.2 Market Development
1.2.1 Current Situation
1.2.2 Aspects of COVID-19 Impact
1.3 By Type
Table Type of Osteoarthritis Drugs
Figure Global Osteoarthritis Drugs Market Share by Type in 2021
1.4 By Application
Table Application of Osteoarthritis Drugs
Figure Global Osteoarthritis Drugs Market Share by Application in 2021
1.5 By Region
Figure Global Osteoarthritis Drugs Market Share by Region in 2021
Figure Asia Osteoarthritis Drugs Market Share by Region in 2021
Part 2 Key Companies
2.1 Johnson & Johnson
2.1.1 Company Profile
Table Johnson & Johnson Overview List
2.1.2 Products & Services Overview
2.1.3 Sales Data List
Table Osteoarthritis Drugs Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
2.2 Pfizer
2.3 Eli Lilly
2.4 Abbott
2.5 GlaxoSmithKline
2.6 Sanofi
2.7 Flexion Therapeutics
Part 3 Global Market Status and Future Forecast
3.1 Global Market by Region
Table Global Osteoarthritis Drugs Market by Region, 2017-2021 (Million USD)
Figure Global Osteoarthritis Drugs Market Share by Region in 2021 (Million USD)
Table Global Osteoarthritis Drugs Market by Region, 2017-2021 (Volume)
Figure Global Osteoarthritis Drugs Market Share by Region in 2021 (Volume)
Table Price List by Region, 2017-2021
3.2 Global Market by Company
Table Global Osteoarthritis Drugs Market by Company, 2017-2021 (Million USD)
Figure Global Osteoarthritis Drugs Market Share by Company in 2021 (Million USD)
Table Global Osteoarthritis Drugs Market by Company, 2017-2021 (Volume)
Figure Global Osteoarthritis Drugs Market Share by Company in 2021 (Volume)
Table Price List by Company, 2017-2021
3.3 Global Market by Type
Table Global Osteoarthritis Drugs Market by Type, 2017-2021 (Million USD)
Figure Global Osteoarthritis Drugs Market Share by Type in 2021 (Million USD)
Table Global Osteoarthritis Drugs Market by Type, 2017-2021 (Volume)
Figure Global Osteoarthritis Drugs Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
3.4 Global Market by Application
Table Global Osteoarthritis Drugs Market by Application, 2017-2021 (Million USD)
Figure Global Osteoarthritis Drugs Market Share by Application in 2021 (Million USD)
Table Global Osteoarthritis Drugs Market by Application, 2017-2021 (Volume)
Figure Global Osteoarthritis Drugs Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
3.5 Global Market by Forecast
Figure Global Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Global Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
Part 4 Asia-Pacific Market Status and Future Forecast
4.1 Asia-Pacific Market by Type
Table Asia-Pacific Osteoarthritis Drugs Market by Type, 2017-2021 (Million USD)
Figure Asia-Pacific Osteoarthritis Drugs Market Share by Type in 2021 (Million USD)
Table Asia-Pacific Osteoarthritis Drugs Market by Type, 2017-2021 (Volume)
Figure Asia-Pacific Osteoarthritis Drugs Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
4.2 Asia-Pacific Market by Application
Table Asia-Pacific Osteoarthritis Drugs Market by Application, 2017-2021 (Million USD)
Figure Asia-Pacific Osteoarthritis Drugs Market Share by Application in 2021 (Million USD)
Table Asia-Pacific Osteoarthritis Drugs Market by Application, 2017-2021 (Volume)
Figure Asia-Pacific Osteoarthritis Drugs Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
4.3 Asia-Pacific Market by Geography
4.3.1 China Market Status and Future Forecast
Figure China Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure China Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure China Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure China Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
4.3.2 Southeast Asia Market Status and Future Forecast
Figure Southeast Asia Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure Southeast Asia Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure Southeast Asia Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Southeast Asia Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
4.3.3 India Market Status and Future Forecast
Figure India Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure India Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure India Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure India Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
4.3.4 Japan Market Status and Future Forecast
Figure Japan Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure Japan Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure Japan Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Japan Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
4.3.5 Korea Market Status and Future Forecast
Figure Korea Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure Korea Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure Korea Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Korea Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
4.3.6 Oceania Market Status and Future Forecast
Figure Oceania Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure Oceania Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure Oceania Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Oceania Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
4.4 Asia-Pacific Market by Forecast
Figure Asia-Pacific Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Asia-Pacific Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
Part 5 Europe Market Status and Future Forecast
5.1 Europe Market by Type
Table Europe Osteoarthritis Drugs Market by Type, 2017-2021 (Million USD)
Figure Europe Osteoarthritis Drugs Market Share by Type in 2021 (Million USD)
Table Europe Osteoarthritis Drugs Market by Type, 2017-2021 (Volume)
Figure Europe Osteoarthritis Drugs Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
5.2 Europe Market by Application
Table Europe Osteoarthritis Drugs Market by Application, 2017-2021 (Million USD)
Figure Europe Osteoarthritis Drugs Market Share by Application in 2021 (Million USD)
Table Europe Osteoarthritis Drugs Market by Application, 2017-2021 (Volume)
Figure Europe Osteoarthritis Drugs Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
5.3 Europe Market by Geography
5.3.1 Germany Market Status and Future Forecast
Figure Germany Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure Germany Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure Germany Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Germany Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
5.3.2 UK Market Status and Future Forecast
Figure UK Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure UK Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure UK Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure UK Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
5.3.3 France Market Status and Future Forecast
Figure France Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure France Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure France Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure France Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
5.3.4 Italy Market Status and Future Forecast
Figure Italy Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure Italy Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure Italy Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Italy Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
5.3.5 Russia Market Status and Future Forecast
Figure Russia Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure Russia Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure Russia Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Russia Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
5.3.6 Spain Market Status and Future Forecast
Figure Spain Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure Spain Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure Spain Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Spain Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
5.3.6 Netherlands Market Status and Future Forecast
Figure Netherlands Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure Netherlands Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure Netherlands Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Netherlands Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
5.3.7 Turkey Market Status and Future Forecast
Figure Turkey Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure Turkey Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure Turkey Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Turkey Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
5.3.6 Switzerland Market Status and Future Forecast
Figure Switzerland Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure Switzerland Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure Switzerland Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Switzerland Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
5.4 Europe Market by Forecast
Figure Europe Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Europe Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
Part 6 North America Market Status and Future Forecast
6.1 North America Market by Type
Table North America Osteoarthritis Drugs Market by Type, 2017-2021 (Million USD)
Figure North America Osteoarthritis Drugs Market Share by Type in 2021 (Million USD)
Table North America Osteoarthritis Drugs Market by Type, 2017-2021 (Volume)
Figure North America Osteoarthritis Drugs Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
6.2 North America Market by Application
Table North America Osteoarthritis Drugs Market by Application, 2017-2021 (Million USD)
Figure North America Osteoarthritis Drugs Market Share by Application in 2021 (Million USD)
Table North America Osteoarthritis Drugs Market by Application, 2017-2021 (Volume)
Figure North America Osteoarthritis Drugs Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
6.3 North America Market by Geography
6.3.1 United States Market Status and Future Forecast
Figure United States Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure United States Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure United States Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure United States Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
6.3.2 Canada Market Status and Future Forecast
Figure Canada Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure Canada Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure Canada Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Canada Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
6.3.3 Mexico Market Status and Future Forecast
Figure Mexico Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure Mexico Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure Mexico Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Mexico Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
6.4 North America Market by Forecast
Figure North America Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure North America Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
Part 7 South America Market Status and Future Forecast
7.1 South America Market by Type
Table South America Osteoarthritis Drugs Market by Type, 2017-2021 (Million USD)
Figure South America Osteoarthritis Drugs Market Share by Type in 2021 (Million USD)
Table South America Osteoarthritis Drugs Market by Type, 2017-2021 (Volume)
Figure South America Osteoarthritis Drugs Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
7.2 South America Market by Application
Table South America Osteoarthritis Drugs Market by Application, 2017-2021 (Million USD)
Figure South America Osteoarthritis Drugs Market Share by Application in 2021 (Million USD)
Table South America Osteoarthritis Drugs Market by Application, 2017-2021 (Volume)
Figure South America Osteoarthritis Drugs Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
7.3 South America Market by Geography
7.3.1 Brazil Market Status and Future Forecast
Figure Brazil Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure Brazil Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure Brazil Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Brazil Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
7.3.2 Argentina Market Status and Future Forecast
Figure Argentina Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure Argentina Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure Argentina Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Argentina Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
7.3.3 Columbia Market Status and Future Forecast
Figure Columbia Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure Columbia Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure Columbia Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Columbia Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
7.3.4 Chile Market Status and Future Forecast
Figure Chile Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure Chile Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure Chile Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Chile Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
7.3.5 Peru Market Status and Future Forecast
Figure Peru Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure Peru Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure Peru Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Peru Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
7.4 South America Market by Forecast
Figure South America Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure South America Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
Part 8 Middle East & Africa Market Status and Future Forecast
8.1 Middle East & Africa Market by Type
Table Middle East & Africa Osteoarthritis Drugs Market by Type, 2017-2021 (Million USD)
Figure Middle East & Africa Osteoarthritis Drugs Market Share by Type in 2021 (Million USD)
Table Middle East & Africa Osteoarthritis Drugs Market by Type, 2017-2021 (Volume)
Figure Middle East & Africa Osteoarthritis Drugs Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
8.2 Middle East & Africa Market by Application
Table Middle East & Africa Osteoarthritis Drugs Market by Application, 2017-2021 (Million USD)
Figure Middle East & Africa Osteoarthritis Drugs Market Share by Application in 2021 (Million USD)
Table Middle East & Africa Osteoarthritis Drugs Market by Application, 2017-2021 (Volume)
Figure Middle East & Africa Osteoarthritis Drugs Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
8.3 Middle East & Africa Market by Geography
8.3.1 GCC Market Status and Future Forecast
Figure GCC Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure GCC Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure GCC Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure GCC Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
8.3.2 North Africa Market Status and Future Forecast
Figure North Africa Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure North Africa Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure North Africa Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure North Africa Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
8.3.3 South Africa Market Status and Future Forecast
Figure South Africa Osteoarthritis Drugs Market Market Status, 2017-2021 (Million USD)
Figure South Africa Osteoarthritis Drugs Market Market Status, 2017-2021 (Volume)
Figure South Africa Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure South Africa Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
8.4 Middle East & Africa Market by Forecast
Figure Middle East & Africa Osteoarthritis Drugs Market Forecast, 2022E-2028F (Million USD)
Figure Middle East & Africa Osteoarthritis Drugs Market Forecast, 2022E-2028F (Volume)
Part 9 Market Features
9.1 Product Features
9.2 Price Features
9.3 Channel Features
9.4 Purchasing Features
Part 10 Investment Opportunity
10.1 Regional Investment Opportunity
10.2 Industry Investment Opportunity
PART 11 Coronavirus Impact
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
Part 12 Conclusion
List of Tables and Figures